Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619-Reference-Cited by-同舟云学术

Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619

Published:2010-02 Issue:2 Volume:202 Page:189.e1-189.e5
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Zelig Craig M.,Paonessa Damian J.,Hoeldtke Nathan J.,Hill Demetrice L.,Foglia Lisa M.,Napolitano Peter G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference25 articles.

1. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network prevention of recurrent delivery by 17-alpha-hydroxyprogesterone caproate;Meis;N Engl J Med,2003

2. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double blind study;da Fonseca;Am J Obstet Gynecol,2003

3. Mechanisms of progesterone action in inhibiting prematurity;Sfakianaki;J Matern Fetal Neonatal Med,2006

4. Myometrial progesterone responsiveness;Mesiano;Semin Reprod Med,2007

5. 17-Hydroxyprogesterone caproate reverses induced vasoconstriction of the fetoplacental arteries by the thromboxane mimetic U46619;Paonessa;Am J Obstet Gynecol,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating maternal hyperglycemic exposure and fetal placental arterial dysfunction in a dual cotyledon, dual perfusion model;Placenta;2018-09

2. Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model;Hypertension;2018-07

3. Micronized progesterone reduces vasoconstriction in the placenta;The Journal of Maternal-Fetal & Neonatal Medicine;2014-09-29